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Mild chronic perturbation 
of inhibition severely alters 
hippocampal function
Min-Yu Sun1,7, Luke Ziolkowski1,7, Peter Lambert  1,6,7, Hong-Jin Shu1, Micah Keiser1, 
nicholas Rensing2, Natasha Warikoo1, Monika Martinek1, Carson Platnick1, Ann Benz1, 
John Bracamontes3, Gustav Akk3,5, Joe Henry Steinbach3,5, Charles F. Zorumski1,4,5, 
Michael Wong2 & Steven Mennerick  1,4,5*
Pentameric GABAA receptors mediate a large share of CNS inhibition. The γ2 subunit is a typical 
constituent. At least 11 mutations in the γ2 subunit cause human epilepsies, making the role of γ2-
containing receptors in brain function of keen basic and translational interest. How small changes to 
inhibition may cause brain abnormalities, including seizure disorders, is unclear. In mice, we perturbed 
fast inhibition with a point mutation T272Y (T6′Y in the second membrane-spanning domain) to the 
γ2 subunit. The mutation imparts resistance to the GABAA receptor antagonist picrotoxin, allowing 
verification of mutant subunit incorporation. We confirmed picrotoxin resistance and biophysical 
properties in recombinant receptors. T6′Y γ2-containing receptors also exhibited faster deactivation 
but unaltered steady-state properties. Adult T6′Y knockin mice exhibited myoclonic seizures and 
abnormal cortical EEG, including abnormal hippocampal-associated theta oscillations. In hippocampal 
slices, picrotoxin-insensitive inhibitory synaptic currents exhibited fast decay. Excitatory/inhibitory 
balance was elevated by an amount expected from the IPSC alteration. Partial pharmacological 
correction of γ2-mediated IPSCs with diazepam restored total EEG power toward baseline, but had 
little effect on the abnormal low-frequency peak in the EEG. The results suggest that at least part of the 
abnormality in brain function arises from the acute effects of truncated inhibition.
GABA is the major inhibitory transmitter in the brain and sculpts activity throughout the lifespan in large part 
by activating ionotropic GABAA receptors (GABAARs). Synaptic GABAARs typically contain a γ subunit, and γ2 
expression level is more abundant than γ11 or γ3.The γ2 subunit is important for pharmacological and biophysical 
properties of GABAA receptors, as well as synaptic receptor localization2–6. Mutations in γ2 may help us under-
stand the role of inhibition in brain functioning and dysfunction. Indeed, several mutations in γ2 result in human 
epilepsy syndromes7,8.
γ2 is a non-obligatory subunit (unnecessary for ligand binding or channel gating), but its presence reduces 
channel deactivation rate6. It is also important for proper targeting of GABAA receptors9. Complete loss of the 
γ2 subunit in mice is lethal, and heterozygote null mice display altered synaptic receptor localization and an 
anxious/depressed behavioral phenotype10,11. The human K328M γ2 mutation, in the M3-M4 extracellular loop 
of the subunit, speeds channel deactivation kinetics without altering steady-state or pharmacological properties 
of GABAA receptors12. These previous observations make γ2 mutations, short of deletion, an attractive target to 
perturb inhibition.
We studied the impact of altered inhibition by engineering a point mutation in the M2 domain of the endoge-
nous mouse γ2 subunit (T6′Y mutation). The mutation we adopted reduces picrotoxin sensitivity of the receptor 
without changing sensitivity to GABA13–15. Picrotoxin insensitivity provides a pharmacological signature, allow-
ing verification that the mutated γ2 subunit (γ2*) subunit is incorporated and trafficking to synaptic sites. We 
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found that recombinant receptors containing the γ2*subunit also exhibit accelerated GABAA deactivation kinet-
ics, similar to a human mutation (K328M), thereby providing a route for controlled and translationally relevant 
disruption of phasic inhibition.
Our results show that mice homozygous for the γ2*subunit exhibit disrupted hippocampal function, meas-
ured with EEG and by c-Fos immunoreactivity. We explored underpinnings of the hippocampal disruption in 
brain slices and observed the expected acceleration of IPSC decay. The disruption altered the balance between 
spontaneous excitation and spontaneous inhibition in CA1 of hippocampus to a degree expected of the mild 
receptor phenotype. Diazepam treatment rescued IPSC kinetics to WT status, but treatment of mutant mice 
at a non-sedative dose only partly restored EEG properties toward the WT profile. We hypothesize that altered 
hippocampal function in adulthood arises from a combination of the primary genetic lesion and additional sec-
ondary consequences, including potential compensatory alterations, of the mutation that remain to be defined. 
The mouse model thus serves as a tool for exploring the consequences of mildly perturbed inhibition.
Methods
Ethical approval. All animal procedures were performed according to NIH guidelines and approved by the 
Washington University Institutional Animal Care and Use Committee, protocol 20180208. Pain and suffering 
was alleviated with appropriate anesthesia and analgesia during tissue harvest and surgical procedures. Animals 
were derived in house as described below and were reared under the care of the Washington University School of 
Medicine Division of Comparative Medicine. Animals had ad libitum access to food and water throughout. Mice 
were euthanized at the end of studies according to NIH guidelines for minimizing pain. Other aspects of animal 
studies are described in the sections below.
Knock-in mice. γ* knock-in (KI) mice were generated using CRISPR/Cas9-based genome editing, as 
described previously16. Briefly, Cas9 mRNA, sgRNA, and ssODN constructs were injected into the cytoplasm and 
pronucleus of fertilized eggs. Injected eggs were cultured at 37 °C under 5% CO2 overnight, after which 20–25 
two-cell stage embryos were transferred into oviducts of pseudopregnant females. The mutant allele of the γ* KI 
mouse was confirmed by PCR based genotyping from tail DNA.
Mosaic founders were bred with WT mice. We screened and identified F1 mice with the desired mutations 
to establish colonies by heterozygote crosses. Littermate WT controls, variably obtained from the γ* KI colony, 
were used for all experiments. Mice were maintained on a mixed C57BL/6CBA background. To confirm that the 
strategy did not result in unintended mutations of the CRISPR/Cas9 approach, we sequenced the entire γ2* gene, 
as well as the top 10 alternative genes likely to be targeted by the guide RNAs in three homozygous WT mice and 
three homozygous γ2* mice. We found no evidence for off-target mutations in these assays.
Slice preparation. Hippocampal slices were prepared from postnatal day 34 (P34) to P57 GABAAR γ* KI or 
WT littermates of both sexes. The ages avoided developmental changes in IPSC kinetics, which stabilize after P2117. 
We used mice of both sexes. Numbers of males and females were approximately balanced in each experiment.
In accordance with protocols approved by the Washington University IACUC, mice were anesthetized deeply 
with isoflurane and decapitated. The brain was removed and glued onto a Leica VT1200 specimen holder. Sagittal 
(300–400 μm) slices were cut in ice-cold, modified artificial cerebrospinal fluid (ACSF) (in mM: 87 NaCl, 75 
sucrose, 25 glucose, 25 NaHCO3, 2.5 KCl, 1.25 NaH2PO4, equilibrated with 95% oxygen −5% CO2 plus 0.5 CaCl2, 
3 MgCl2; 320 mosmol). Slices were then incubated at 32–34 °C for 30 min in choline-based ACSF (in mM: 92 
choline chloride, 25 glucose, 30 NaHCO3, 2.5 KCl, 1.2 NaH2PO4, 20 HEPES, 2 thiourea, 5 Na ascorbate, 3 Na 
pyruvate, 2 CaCl2 and 1 MgCl2, equilibrated with 95% oxygen-5% CO2; 300 mosmol), and subsequently stored at 
room temperature in regular ACSF (in mM: 125 NaCl, 25 glucose, 25 NaHCO3, 2.5 KCl, 1.25 NaH2PO4, equili-
brated with 95% oxygen-5% CO2 plus 2.6 CaCl2, 1.2 MgCl2; 310 mosmol), allowing for at least one hour recovery 
prior to experiments. Except for noted exceptions, drugs were obtained from Sigma (St. Louis, MO).
Whole-cell patch-clamp recording in slices. Slices were transferred to a recording chamber and con-
tinuously perfused with oxygenated, regular ACSF at 2 ml min−1. Experiments were performed at 30–32 °C. 
Somatic, whole-cell patch-clamp recordings were performed using differential contrast interference microscopy 
under infrared illumination. Dentate granule cells (DGCs) or CA1 cells were identified on an upright Nikon 
Eclipse E600FN microscope using a QImaging camera controlled with QCapture (QImaging, Surrey, Canada). 
Somatic whole cell recordings were made with borosilicate patch pipettes (World Precision Instruments, Sarasota, 
FL; Sutter Instruments, Novato, CA), having open tip resistance of 3–7 MΩ. After a whole-cell configuration 
was established, cells were allowed to fill with the intracellular solution for ∼5 min. Recordings were obtained 
using a MultiClamp 700B amplifier (Molecular Devices; Sunnyvale, CA), Digidata1550 16-bit A/D converter, 
and pClamp 10.4 software (Molecular Devices). Pipette capacitance was compensated using MultiClamp 700B 
Commander software. Somatic access resistance values were between 10–25 MΩ, and cells with unstable access 
resistance (>20% change) were excluded from analysis.
Measurement of spontaneous EPSCs and IPSCs. For calculating the ratio of spontaneous EPSCs (sEP-
SCs) and IPSCs (sIPSCs), cells were held at −60 mV and 0 mV, respectively, with an intracellular pipette solution 
containing (in mM): 120 cesium methanesulfonate, 20 HEPES, 10 EGTA, 2 MgATP, 0.3 Na2GTP, and 5 QX-314; 
pH was adjusted with CsOH to pH 7.25 (290 mosmol). No receptor antagonists were present for this experiment. 
To verify diazepam’s effects on GABAA responses, pharmacologically isolated sIPSCs were recorded at −70 mV 
with an intracellular pipette solution containing (in mM): 130 CsCl, 10 HEPES, 5 EGTA, 2 MgATP, 0.5 NaGTP, 
and 4 QX-314; pH was adjusted with CsOH to pH 7.3; 290 mosomol. GABAAR sIPSCs were isolated by blocking 
ionotropic glutamate receptors with 10 μM NBQX (Tocris, Bristol, United Kingdom) and 50 μM D-APV (Tocris). 
All the sEPSC and sIPSC data were acquired in gap-free mode at 5 kHz, filtered at 2 kHz using an 8-pole Bessel filter.
3Scientific RepoRtS |         (2019) 9:16431  | https://doi.org/10.1038/s41598-019-52851-w
www.nature.com/scientificreportswww.nature.com/scientificreports/
CA1 Field EPSP (fEPSP) recording. Extracellular field excitatory postsynaptic potentials (fEPSPs) were 
recorded in CA1 stratum radiatum 50 μm below the pyramidal cell layer with glass electrodes (1 MΩ) filled with 
ACSF. Stimuli were delivered to the commissural/Schaffer collateral afferents with a concentric bipolar electrode 
positioned parallel to the recording electrode ~500 μm away. Input/output curves were generated by increment-
ing the stimulation amplitude from 50 to 600 μA. The standard stimulation intensity for trains was set to an 
intensity that evoked 50–75% of the maximal fEPSP amplitude. A 50 Hz, 5-pulse train was then applied every 20 s 
for 20 times, and data were analyzed from averaging the 20 sweeps. fEPSP slope was measured from ~20–80% of 
the peak.
Sholl analysis. DGCs were patched and infused with CsCl-based internal solution containing 0.1% 
Lucifer Yellow CH dilithium salt (Sigma L0259). After staining for 10–15 minutes, the pipette was with-
drawn from the cell, and the slice was fixed in 4% PFA for 10 minutes, followed by 3 washes with PBS. The 
slice was then incubated in blocking solution containing 5% sucrose, 2% BSA, and 1% Triton X-100 in PBS 
for 1 hr. Next, the slice was incubated with anti-Lucifer Yellow rabbit primary antibody (1:2000, Thermo 
Fisher Scientific Cat# A-5750, RRID:AB_2536190) diluted in blocking solution for 2 hr. After rinsing 3 
times with PBS, the slice was incubated in a goat anti-rabbit secondary antibody (Alexa Fluor 488, 1:200, 
Invitrogen) diluted in PBS for 1 hr. All incubations were at room temperature. The slice was then mounted 
on a glass slide.
Following immunofluorescence staining, the Lucifer Yellow-filled cells were scanned using a Nikon C1 confo-
cal attachment on a Nikon TE2000 inverted microscope platform with a 60X objective. Z-series stacks were taken 
to include the entire dendritic arbor of each cell (around 60 μm each) with a thickness of around 1 μm. Multiple 
(2–3) z-series were taken in order to fully capture each cell, and the cells were reconstructed from the z-series 
using the pairwise stitching function in ImageJ. Dendritic arbors were skeletonized using the Simple Neurite 
Tracer plugin18, and analyzed using the Sholl Analysis plugin with the soma as the center point and 10 μm inter-
vals between concentric circles19.
Other immunostaining. Other primary antibodies used include rabbit anti-c-Fos (1:1000; Millipore 
Cat# ABE457, RRID:AB_2631318, rabbit anti-somatostatin (1:1000; Peninsula Laboratories Cat# T-4103.0050, 
RRID:AB_518614), and rabbit anti-parvalbumin (1:1000; Swant Cat# PV-28, RRID:AB_2315235). In each case 
visualization was achieved as described above.
N2A cell transfection. Murine neuro-2a (N2a; ATCC Cat# CCL-131, RRID:CVCL_0470) cells were cul-
tured in DMEM with 10% FBS, 2 mM glutamine plus 100 U/ml penicillin, and 0.1 mg/ml streptomycin in 5% CO2 
and 95% air. Cells were transiently transfected with α1, β2, and either WT γ2 or edited γ2* subunit plasmid DNA 
during 4 hour incubation in serum-free medium and Lipofectamine 2000 reagent (Invitrogen) at 37 °C.
Culture electrophysiology. Whole-cell and cell-attached patch-clamp recordings of transfected N2a cells 
were obtained on an Eclipse TE2000-S inverted microscope using a MultiClamp 700B amplifier, Digidata 1550 
16-bit A/D converter and pClamp 10.4 for data collection. Whole-cell recordings were performed with boro-
silicate patch pipettes of 3–7 MΩ containing (in mM): 130 CsCl, 4 NaCL, 10 HEPES, 5 EGTA, and 0.5 CaCl2. 
Extracellular solution typically contained (in mM): 138 NaCl, 4 KCl, 10 HEPES, 2 CaCl2, 1 MgCl2 and 10 glu-
cose. Some recordings of reversal potential were obtained with methanesulfonate substitution for chloride. Cells 
were voltage clamped at −70 mV for whole-cell recordings unless otherwise indicated. For cell-attached single 
channel recordings, patch pipettes contained 50 µM GABA in the described extracellular solution and cells were 
voltage clamped at approximately −60 mV. Data were sampled at 50 kHz and filtered at 2 kHz. Clusters of chan-
nel openings were isolated for analysis as described20. For experiments using local drug delivery, solutions were 
flowed onto cells using a gravity-driven perfusion system with exchange times of ~100 ms. Fast application (~1 ms 
exchange times) of solution was achieved by rapidly switching between two solution flows from a theta-pipette 
attached to a piezo-electric actuator. Junction currents obtained following patch blow-out are shown above traces 
to indicate drug delivery and removal speed.
EEG surgery and recording. Methods were as previously described21. In brief, mice of both sexes were 
anesthetized with isoflurane (5% for induction, 1.5–2% for surgery), and mounted in a stereotactic frame (Kopf, 
Tujunga, CA). Bilateral holes were drilled in the skull for attachment of epidural EEG screw electrodes, a ref-
erence, and a ground. For depth recordings, wires were inserted into the hippocampus, and sites were verified 
upon euthanasia of the animals at the end of recording. Animals recovered for 3 days before initiating video EEG 
monitoring.
Statistics. For sEPSCs and sIPSCs, events were detected using a template-matching algorithm in Clampfit 
(Clements and Bekkers, 1997); templates were created by averaging >20 events. For quantification of total 
charge, Clampfit statistics for area measurement was used on the extracted events after subtraction of baseline 
current. Decay times were assigned based on single or bi-exponential least-squares fits as appropriate. For 
bi-exponential fits, we collapsed the two components into an overall weighted decay time constant for pooling 
and for comparisons. The weighted time constant was calculated as ΣAi*τi, where Ai is the fractional amplitude 
and τi is the time constant of the component. For determining the effects of 5 Hz, 5-pulse stimulus trains on 
CA1 fEPSPs, 20 trials were averaged, and the 2nd-5th test fEPSP slopes were normalized to the slope of the 
initial average conditioning fEPSP slope. Single-channel data were analyzed by modeling channel open and 
closed states in QuB software.
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To generate EEG power spectra, vigilance states were scored manually in 15 second epochs as either “Active” 
or “Inactive” during the animal’s dark cycle using Stellate Reviewer software. For active segments, our analysis 
criteria required movement for a (1–5 min) block, within which periods of inactivity were no more than 15 s each. 
Multiple active segments were concatenated for analysis. For diazepam experiments, segments were taken from 
all periods of activity during the hour immediately following the injection. We manually rejected segments con-
taining >1 Hz voltage spikes of >1000 μV or containing signal dropout. Data were collected at a rate of 200 Hz, 
and bandpass filtered at 1–100 Hz with a digital notch filter at 60 Hz. Selected active periods were exported to 
Clampfit, where power spectra were calculated by fast Fourier transform with a Von Hann window, using the 
average of 512 spectral segments with 50% window overlap. The mean power spectrum for the two hemispheres 
was calculated to represent each animal. Power in each frequency bin was then normalized to the total area of the 
Figure 1. GABA responses from N2a cells expressing WT γ2 or γ2*, with WT α1 and β2. (A) GABA responses 
(100 μM) ± 100 µM PTX from representative WT and γ2* expressing cells. (B) Summary of 8 cells. *P = 0.013 
by Welch’s t test. (C) Responses from increasing concentrations of GABA (1, 3, 10, 30, and 100 μM) from 
representative WT and γ2* expressing cells in the absence of PTX (N2a cells). (D) Dose-response curves of WT 
(n = 9) and γ2* (n = 10) expressing cells, fit with the Hill equation and yielding similar EC50 values (see text). 
(E) Reversal potential of WT and γ2* receptors obtained with a cesium methanesulfonate solution as detailed in 
the Methods.
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spectrum (1–100 Hz). Frequency peaks were found using a Matlab script that was set to find all local maxima that 
were larger than the surrounding data points by a value of at least 1/24 the range of amplitude values. Frequency 
bands were defined as follows (in Hz): δ 1–5, θ 5–9, α 9–12, β 12–30, γ 30–100. Power from frequencies between 
55–65 Hz was excluded from the analysis of the power spectra.
Cells or patches served as the statistical basis of N for all electrophysiology and morphology experiments; ani-
mal number is reported in figure legends. Student’s independent, two-tailed t-tests were performed to determine 
statistical significance between the means of two groups. For detecting interaction between two genotypes at mul-
tiple times, two-way ANOVA and Bonferroni corrected, post hoc analyses were performed. For immunostaining 
results, stains were performed in paired rounds of matched WT and γ2* animals. Because age, litter, time of day, 
staining reagents, etc. were matched for each round of staining, we employed a dependent sample design22. For 
multiple group (>2 groups) comparisons, one way ANOVA and Bonferroni corrected, post hoc analyses were 
performed. For comparisons of EEG bands with multiple t tests, false discovery rate was controlled by a two-stage 
linear step-up procedure of Benjamini, Krieiger, and Yekutielli, with the desired false discovery rate set at 1%. For 
detection of effects within cells, a paired t-test was performed. Statistical analysis was performed using GraphPad 
Prism 7 or 8 (GraphPad Software, San Diego, California). For clarity, specific tests are described in the Results and 
figure legends. In figures significance is displayed at the level of *p ≤ 0.05, **0.01, and ***0.001. Actual P values 
are given where practical. Summary data are presented as mean ± standard error of the mean (SEM). All original 
data are available by request from the authors.
Figure 2. Faster γ2* deactivation. (A) Response of nucleated patches from N2a cells to 1 ms application of 
GABA. Upper trace: open tip current showing application speed. (B) Summary. *P = 0.025, two-tailed t test. 
(C) Voltage-pulse relaxation test of deactivation kinetics. * P Non-GABA currents are subtracted. (D) Tau 
of tail currents measured at −70 mV (arrows in C). *P = 0.021, two-tailed t test. (E) Sample single-channel 
records from a cell-attached patch on N2a cells expressing the indicated subunits. Open state is up. The lower 
panels show log-binned counts of open times from samples of the two subunit variants. The fits are to three 
components. (F) Average weighted mean open time for each patch. *P = 0.035 two-tailed t test.
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Results
Consistent with previous results, we confirmed with recombinant receptor subunits, expressed in N2a cells, that 
γ2* subunit-containing receptors, transfected with WT α1 and β2 subunits, imparted picrotoxin resistance and 
failed to alter GABA concentration-response characteristics (Fig. 1A–D)13. The response of WT receptors to 
picrotoxin exhibited the appearance of a rapidly desensitizing current (Fig. 1A), consistent with previously doc-
umented activation dependence of picrotoxin inhibition23,24. The GABA EC50 values for WT and mutant recep-
tors did not differ statistically at 11.5 and 14.1 μM respectively. Macroscopic desensitization percentage with 5 s 
at 100 μM GABA also did not detectably differ (53 ± 6% WT vs. 45 ± 4% γ2*, P = 0.29). Reversal potential of 
currents with a low [Cl−] pipette solution was indistinguishable from WT receptors (Fig. 1E), suggesting similar 
Cl− permeability.
On the other hand, γ2* receptors in excised outside-out patches responded to synaptic-like, 1 ms pulses of 
100 μM GABA with faster deactivation than receptors containing WT γ2 (Fig. 2A,B). We confirmed the altered 
kinetics with two additional, independent approaches. First, we exploited the voltage dependence of receptor 
gating at low [GABA]25. This approach originates from the finding, first made with nicotinic acetylcholine recep-
tors, that voltage-pulse relaxations can be used to monitor changes in channel gating26. At 2 μM, leak-subtracted 
GABA-induced currents exhibited a time-dependent growth at +50 mV (Fig. 2C,D), reflecting voltage dependent 
increase in channel open probability26. Upon return to −70 mV, the current relaxed back to the original steady 
state value with an exponential time constant (Fig. 2C,D). This relaxation was faster in mutant receptors, confirm-
ing a kinetic difference between γ2* and WT γ2 receptors. This experiment employed a low GABA concentration 
because at high GABA concentration, the voltage dependence of GABAAR gating disappears27.
Second, we examined behavior of single channels gated by 50 µM GABA in cell-attached patches obtained 
from N2a cells. We used a high concentration of GABA to promote long-lived desensitized states, thereby pro-
moting separation of bursts of channel activity20. Here we analyzed channel open times and closed times in bursts 
of channel activity, as previously described20. We found that γ2* channels exhibited lower mean open times than 
WT γ2 channels (Fig. 2E,F), offering a substrate for the altered deactivation kinetics observed in experiments 
on macroscopic currents. The same data set yielded no evidence for a difference in channel closed times (WT, 
1.7 ± 0.2 ms vs. γ2*, 2.1 ± 0.4 ms, P = 0.4 Student’s t test).
Amino acid residues in the γ2 subunit, along with α subunit residues, are critical for potentiation by ben-
zodiazepines28,29. Although the site for benzodiazepine binding is distant from the T6′Y mutation, long-range 
interference could be possible. Lorazepam (1 µM) evoked similar potentiation from N2a cells expressing γ2 and 
γ2* receptors (Fig. 3A,B). Similarly, a broad-spectrum (subunit-independent) potentiator, pentobarbital, also 
retained activity at γ2* receptors similar to WT γ2 receptors (Fig. 3C). These results suggest that receptors con-
taining the mutated γ2* subunit maintain normal pharmacological responsiveness.
These results demonstrate that γ2* may be a tool to selectively perturb phasic inhibition in vivo. The observed 
changes to receptor function phenocopy properties of the K328M human epilepsy mutation, as documented 
in previous studies of heterologous cells and cultured rodent neurons12,30. The picrotoxin resistance in the γ2* 
Figure 3. Allosteric potentiation intact in γ2*. (A) Sample traces from transfected N2a cells with WT α1 and 
β2 subunits, with the indicated γ2 subunit: 1 μM lorazepam at 2 μM GABA. (B,C) Summary of the effects of 
lorazepam and 50 µM pentobarbital, at 2 μM GABA. P = 0.912 lorazepam and P = 0.470, Student’s unpaired t 
tests.
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mutation allows verification of subunit incorporation in a manner not possible with the human mutation. The 
selective changes to non-equilibrium responses mean that tonic currents mediated by γ2* should not be dis-
turbed. Thus, to study the impact of the perturbation to phasic inhibition, we made a mouse line in which the 
endogenous γ2 gene was edited with the T6′Y mutation and became picrotoxin resistant (γ2*).
Mice homozygous for γ2* seemed to develop normally early, but tended to die prematurely. In a represent-
ative three month span out of 26 homozygote knock-in births, 11 animals died in their home cages before they 
were able to be used for experiments at an average age of 87.4 days. This never occurred with WT littermates. 
Prior to death, γ2* mice were of normal weight (22.6 g vs. 21.0 g for WT littermates at P50; P = 0.332). However, 
mutant mice exhibited occasional behavioral myoclonic jerks associated with spikes in cortical EEG (Fig. 4A–C). 
Death appeared to be associated with a large generalized seizure, confirmed behaviorally by video (Fig. 4C, inset). 
Heterozygotes displayed no obvious behavioral or lifespan differences from WT. To probe for brain abnormal-
ities, we analyzed cortical EEG recordings during active wake periods from WT and γ2* littermates at P40–60. 
During active exploration, power spectra from WT animals exhibited strong power in theta (6–9 Hz) frequencies, 
as expected31,32 (Fig. 4). γ2* Littermates demonstrated higher power than WT at frequencies up to 20 Hz. In the 
gamma frequency range, power was reduced in γ2* animals (Fig. 4D,E). Aside from these overall amplitude 
changes, the prominent theta peak associated with active exploration in WT animals was not present in γ2* ani-
mals and appeared to shift into the delta (3–5 Hz) frequency range (Fig. 4D,F).
To confirm the changes in theta during active wake are evident in hippocampus, we performed depth EEG 
recordings from hippocampus. These recordings showed a very similar power spectrum during active wake as 
cortical EEGs (Fig. 5) and confirmed abnormal hippocampal function.
We further explored hippocampal function related to spontaneous activity using c-Fos immunoreactivity. 
c-Fos is commonly used as a marker of integrated electrical activity33,34. We euthanized paired WT and γ2* 
animals directly from their home cages, and immunostained frozen tissue sections for c-Fos immunoreactivity. 
Homozygous γ2* animals exhibited a reduced number of c-Fos+ cells in the granule cell layer of the dentate com-
pared with matched WT animals (Fig. 6A). The intensity of labeled neurons in the dentate granule cell layer did 
not clearly differ between genotypes (22 ± 17% lower fluorescence in paired mutant animals). The weaker c-Fos 
activation results support the idea of abnormal hippocampal activity in a major input layer to the hippocampal 
Figure 4. Cortical EEG abnormalities in γ2* mice. (A–C) Sample cortical EEG traces from WT and γ2* 
animals. The spikes in panel C were associated with myoclonic jerks. The inset shows brain activity preceding 
death in one γ2* animal. (D) Mean active wake power spectra from WT (Black n = 18) and γ2* (Red n = 18) 
animals Shading represents standard error. (E) Power of total spectrum and frequency bands shown in (D) 
(unpaired, corrected Student’s t tests, adjusted for false discovery, with asterisks indicating p value levels as 
given in the Methods). (F) Active wake power spectra normalized to total power of spectrum. (G) Frequency 
distribution of relative power (two-way ANOVA Genotype X Frequency Band shows significant interaction, 
(F (4, 136) = 45.90; P < 10−15). Results of individual corrected t tests are shown. (H) Peak location in the low 
frequency bands of the active wake power spectrum (unpaired Student’s t-test, P < 1e-4).
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circuit. Labeling was generally not evident in either genotype in the CA1 region, making comparison difficult. 
Also, we note that the technique does not distinguish between lower overall activity or more distributed activity 
at levels sub-threshold for activating c-Fos. Further, sensitivity of c-Fos may not be sufficient to detect subtle 
changes to activity.
We assessed changes to interneuron density by staining for somatostatin, which labels mainly 
dendrite-targeting interneurons and for parvalbumin, which labels mainly soma-targeting interneurons. We 
found no difference in the density of either cell type, suggesting that secondary changes to interneuron numbers 
are unlikely to explain the reduced c-Fos staining or the abnormal EEG (Fig. 6B,C). To test whether secondary 
changes to granule cell morphology might explain the differences in c-Fos immunoreactivity, we performed a 
Sholl analysis of granule neuron dendritic morphology. The mutant granule cells showed dendritic branching 
patterns comparable to that of WT cells (Fig. 6D).
Given that the anatomical changes examined did not readily explain hippocampal functional differences, we 
turned to ex vivo slices to examine spontaneous synaptic activity in DGCs, the main input relay cells of the hip-
pocampus, and in CA1 pyramidal neurons. Spontaneous IPSCs exhibited the accelerated decay expected from 
studies of recombinant receptors (Fig. 7A,B,F,G; Supplementary Figure S1). However, the total charge of sIPSCs 
was unaltered in DGCs and was only altered by an amount expected of the change of IPSC decay in CA1 pyrami-
dal neurons (Fig. 7E,J; Supplementary Figure S1). sEPSCs were not altered detectably in either cell type (Fig. 7D,I; 
Supplementary Figure S1). Altered sIPSCs did not result from exclusion of γ2* from receptors or from substitu-
tion by another subunit because sIPSCs were mostly insensitive to PTX (100 μM), a concentration that abolished 
sIPSCs in WT slices16.
To survey acute and secondary impact of the γ2* subunit on synaptic properties of DGCs, we examined the 
excitation to inhibition ratio (E/I ratio) in DGCs by summing the postsynaptic charge transfer of EPSCs and 
IPSCs over 60 s at the respective reversal potentials in order to isolate excitation and inhibition (Fig. 7). Pilot 
experiments identified the reversal potential for pharmacologically isolated IPSCs to be near −60 mV under these 
conditions. We found no statistical difference in the E/I ratio in pooled WT and γ2* data for DGCs (Fig. 7C), 
although the direction of the mean IPSC charge (Q) and E/I ratio was altered as expected from the truncated 
IPSCs (Fig. 7D,E). The result suggests that the IPSC decay difference is sufficiently subtle to be masked by varia-
bility in sIPSC frequency and amplitude. The same analysis of E/I ratio and integrated excitation and inhibition 
values was performed on CA1 pyramidal neurons (Fig. 7F–J). In this case, the elevated E/I ratio reached a sta-
tistical threshold of  P < 0.05 (Fig. 7H) in the direction expected from the change in inhibition. Only inhibitory 
charge was detectably reduced, suggesting that accelerated γ2* IPSCs explain the difference in E/I ratio. Overall, 
the change to inhibition in DGCs and CA1 cells paralleled the effect size of the change to E/I ratio and thus likely 
drives the E/I balance difference in γ2* cells.
We reasoned that the impact of altered inhibition may be more evident in the summed activity of many neu-
rons, during trains of impulses, where both feedforward and feedback inhibition would participate. Surprisingly, 
we found no evidence that the input/output characteristics of dendritic CA1 fEPSPs evoked by stimulation in 
the Shaffer collateral pathway were impacted by γ2* (Fig. 8A–C). Decays of fEPSP waveforms were not demon-
strably different, with decay time constants of 5.8 ± 0.8 and 4.9 ± 0.7 ms for WT and γ2* respectively (n = 6 
each, P = 0.44). We further observed no change in the fEPSPs evoked by short 50 Hz trains (Fig. 8D–F). These 
results again suggest a mild impact of γ2* at the cellular and synaptic level in hippocampus.
If the impact of γ2* is mainly through the acute acceleration of IPSC deactivation, then we might expect to 
rescue the phenotype of γ2* animals by a pharmacological intervention that prolongs IPSCs, thereby restoring 
WT status. For this test, benzodiazepines are a good choice because they require the presence of a γ2 subunit, 
and our studies with recombinant receptors demonstrated that the mutant γ2 subunit retains benzodiazepine 
sensitivity (Fig. 3). To verify this in native cells, we recorded sIPSCs from DGCs in hippocampal slices (Fig. 9). 
Application of 1 μM diazepam prolonged both WT and γ2* IPSC decays as expected. The weighted time constant 
of γ2* IPSCs treated with diazepam was statistically indistinguishable from baseline WT IPSCs (Fig. 9B), sug-
gesting that diazepam could be an effective pharmacological rescue strategy for the acute effects of the mutation.
Figure 5. Hippocampal depth recordings recapitulate the EEG abnormality. (A) Normalized active wake power 
spectra from hippocampal depth electrodes (WT-Black γ2*-Red, n = 4 animals). (B) Frequency distribution 
of relative power (two-way ANOVA Genotype X Frequency showed significant interaction. F(4,24) = 15.50, 
P = 2e-6).
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We next injected mice with 0.75 mg/kg diazepam (i.m.), which proved in pilot observations of spontaneous 
locomotion to be just sub-sedative in both genotypes. Cortical EEG from bouts of active exploration showed 
no discernible impact of diazepam in WT mice (Fig. 10A,B). By contrast, γ2* EEG proved more pharmacolog-
ically malleable. The higher power of low frequencies observed in γ2* baseline EEG was mitigated by diazepam 
(Fig. 10C,D). On the other hand, diazepam did not clearly restore the theta peak to the 6–8 Hz range observed 
in WT animals. The restoration of γ2* EEG power toward the WT profile can be seen in a plot of the percent 
difference in power at each frequency for each genotype and drug condition, compared with the WT baseline 
condition (Fig. 10C, inset). The changes to EEG were not associated with differences in the behavioral sensitivity 
of the two genotypes to diazepam. Both groups had similar amounts of activity for an hour following diazepam 
injection, based on video ratings (WT: 32:32 ± 2:13; γ2*: 37:52 ± 4:29 of activity). We conclude that the γ2* EEG 
can be partly rescued by pharmacological restoration of IPSCs, but latent secondary changes not amenable to 
pharmacological rescue may also contribute.
Figure 6. Depressed c-Fos immunolabeling in γ2* dentate in the absence of altered interneuron density 
or DGC morphological abnormalities. (A) c-Fos-positive DGC density in WT and γ2* KI slices. (N = 10 
littermates per genotype, ages 31–100 days, P = *0.012; two-tailed paired t-test). (B) Somatostatin-positive 
cell density in the hilus of WT and γ2* KI slices. (N = 10 animals, P = 0.579; two-tailed paired t-test). (C) 
Parvalbumin-positive cell density in the dentate gyrus of WT and γ2* KI slices.KI slices. (n = 10 animals, 
P = 0.267; two-tailed paired t-test). Connected symbols in the graphs represent biological replicates of littermate 
pairs stained as a pair. (D) Representative confocal image of a Lucifer Yellow-filled DGC and subsequent Sholl 
Analysis comparing dendrite complexity of WT and γ2* KI DGCs. (n = 11 WT cells from 8 animals and 12 γ2* 
KI cells from 6 animals; P > 0.999; two-way repeated measures ANOVA).
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Discussion
Our results show that mice homozygous for a mutation in the non-obligatory γ2 subunit exhibit disrupted hip-
pocampal function, measured by EEG and c-Fos immunoreactivity. The underpinnings of the disruptions appear 
mild at the cellular and micro-circuit level, but are magnified at the level of cortical EEG. Pharmacological rescue 
of the cellular phenotype partially restores the EEG. Overall, our results demonstrate that chronic, mild pertur-
bation of inhibition has a large impact on hippocampal function, consistent with human mutations in GABAA 
receptor subunits. The mouse model we developed here represents a tractable system for exploring the impact of 
a well-characterized mutation on inhibition’s role in development and function.
Although we presented biophysical differences in receptor function early in the presentation of results, in truth 
our initial strategy sought to follow a path laid out in the development of mice carrying benzodiazepine-resistant 
subunits28. The idea was to generate mice whose GABA function is intact but that resist antagonism by picrotoxin, 
in order to separate cellular contributions of receptors bearing different non-obligatory subunits16. Past evidence 
suggested that the T6′Y amino acid substitution has no effect on basal function13. However, the behavioral phe-
notypes of the resulting mice caused us to perform a more detailed accounting of biophysical parameters of the 
mutated receptors. We confirmed previous work that found no change in the steady-state properties of receptors 
containing γ2*13. However, non-steady-state kinetics were accelerated, including IPSC decays in mouse neurons 
and deactivation of recombinant receptors to brief GABA applications. The lack of change to sIPSC amplitude or 
frequency16 suggest that the kinetic change is largely responsible for driving the phenotypes. A lack of change to 
GABA EC50 with accelerated deactivation kinetics also characterize the human K328M epilepsy mutation12. More 
work will be needed to reconcile the lack of change in sustained responses with the change in deactivation kinetics 
in these mutations. One possibility is that an undetected decrease in activation rate, not evident at high [GABA], 
could balance the decreased deactivation to leave GABA EC50 unchanged.
Because the mutation disrupts excitatory/inhibitory balance in favor of excitation and seizures, it may be sur-
prising that a marker of integrated neural activity, c-Fos immunoreactivity, showed fewer positive cells in mutant 
hippocampi. At least two considerations may help explain the paradox. First, animals were not euthanized during 
or immediately after seizures. Therefore, hippocampal c-Fos expression was not likely the direct result of seizure 
activity. Second, the decrease of integrated activity likely reflects complicated circuit effects of the mutation, pos-
sibly even extrinsic to the hippocampus.
Figure 7. Excitation/Inhibition (E/I) ratio is modestly elevated in hippocampal CA1 neurons from γ* KI slices. 
(A) Representative traces of sEPSCs and sIPSCs from DGCs in WT vs γ2* KI slices. (B) Averaged waveform 
of sIPSCs from DGCs in representative WT and γ2* KI slices and pooled data, revealing the accelerated decay 
of γ2* IPSCs (P < ***1e-5). (C–E) Summary of E/I charge ratio, total charge transfer for EPSCs and IPSCs in 
WT vs γ2* KI DGCs (N = 8 WT cells from 2 animals and 9 γ2* KI cells from 2 animals, P = 0.708, 0.455 and 
0.518, respectively; 2 tails independent t test). (F) Representative traces of sEPSCs and sIPSCs from CA1 cells in 
WT vs γ2* KI slices. (G) Average waveform of sIPSCs from representative CA1 cells in WT and γ2* KI slices, 
revealing the accelerated decay of γ2* IPSCs (P = **0.007). (H–J) Summary of E/I charge ratio, total charge 
trasfer for EPSCs and IPSCs from WT vs γ2* KI CA1 cells (N = 9 WT cells from 4 animals and 14 γ2* KI cells 
from 4 animals, P = *0.020, 0.361 and *0.014, respectively; 2 tails independent t test).
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In principle, the change to inhibition could directly account for functional abnormalities, but constitutively 
altered inhibition could also cause secondary compensatory or pathological changes, leading to alterations that 
are less amenable to acute rescue of receptor kinetics. Our results detected no changes to the structure of prin-
cipal neurons of the dentate gyrus or to numbers of several interneuron classes. Further, acute pharmacological 
intervention with diazepam had stronger impact on the EEG of mutant animals than WT animals and partially 
reverted the EEG phenotype. Thus, a specific secondary change was not evident under baseline conditions that 
would obviously contribute to altered hippocampal theta rhythm. Physiological evidence of circuit behavior in 
Figure 8. CA1 fEPSPs in response to a train of stimulus pulses are unaltered from γ* KI slices. (A,B) 
Representative traces of fEPSPs evoked in CA1 area from WT vs γ2* KI slices. (C) Input-output curve (peak 
amplitude vs stimulus intensity) of CA1 fEPSPs from WT (black) vs γ2* KI (red) slices. Genotype comparison: 
P = 0.211, two-way repeated measures ANOVA. (D,E) Representative traces of CA1 fEPSPs evoked by a 50 Hz, 5 
pulses train from WT vs γ2* KI slices. (F) The 2nd–5th fEPSP slope is normalized to the 1st fEPSP slope following 
the 50 Hz, 5 pulse trains, from WT (black) vs γ2* KI (red) slices. N = 5 WT slices from 2 animals and 5 γ2* KI 
slices from 2 animals. Genotype comparison: P = 0.977, two-way repeated measures ANOVA.
Figure 9. Diazepam rescues the γ2 sIPSC decay to near the WT level. (A) Representative traces of sIPSCs from 
WT vs γ2* KI DGCs, before (black) and after (red) 1 μM diazepam application. Insets showed normalized 
peak sIPSCs before and after diazepam for each genotype. (B) Summary of decay tau before and after 1 μM 
diazepam application, from DGCs in WT vs γ2* KI slices. N = 5 WT cells from 1 animal and 8 γ2* KI cells from 
2 animals, P = ***0.001 for WT baseline vs WT diazepam; P = ***0.001 for WT baseline vs γ2* KI baseline; 
P = 0.226 for WT baseline vs γ2* KI diazepam; P = *0.032 for γ2* KI baseline vs γ2* KI diazepam; one-way 
ANOVA and Bonferroni’s multiple comparisons test.
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hippocampus, assayed through sEPSCs and sIPSCs and through evoked fEPSPs revealed no evidence for sec-
ondary changes that impact excitability or synaptic transmission in hippocampus. On the other hand, we cannot 
exclude the possibility of contributing secondary consequences since the effect of diazepam was partial. Further, 
we previously detected a depression of mIPSC frequency in these animals, presumably representing a secondary 
effect16. Ultimately, genetic restoration of WT γ2 at different times and locations should yield insight into second-
ary vs. acute explanations for the EEG phenotype.
Regardless of whether changes leading to the EEG phenotype are direct or secondary, the paradox between small 
cellular changes (slight acceleration of IPSCs, minimally disrupted E/I ratio) and a large EEG and altered c-Fos phe-
notype deserves further exploration. Future work may gain additional insight through meso-level in vivo or in vitro 
analyses, such as local field potential recordings or photometry. Cell-type selective knock-ins could also in principle 
yield insight because interneuron-selective γ2 knockouts exhibit phenotypic similarities to the γ2* mice35. It seems 
likely that ensemble-level disruptions of coordinated activity are likely to underlie the γ2* phenotype.
The γ2* mutation may offer a tractable model of genetic epilepsies. At least 11 different mutations in γ2 
subunits characterize human epilepsy-related syndromes12. The T6′Y mutation is particularly reminiscent of the 
human K328M mutation12. The pharmacological fingerprint offered by the T6′Y mutation offers experimental 
tractability not offered by human mutations. For instance, in human mutations of GABAA receptor subunits, the 
incorporation of the mutant subunit cannot readily be experimentally verified. Picrotoxin insensitivity allows us 
to exclude trafficking and incorporation deficits as explanations for abnormal functioning.
In summary, we introduce a model for exploring how small changes to inhibition can lead to large abnormal-
ities in brain functioning. The deficiencies incurred appear to lie at the meso-level of population dynamics, since 
cellular changes are minimal. The results highlight the key role that finely tuned inhibition plays in coordinated 
function of CNS function.
Data availability
The datasets generated and analyzed during the current study are available from the corresponding author on 
reasonable request.
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Figure 10. Diazepam reduces overall EEG power selectively in γ2* animals. (A) Active wake power spectra 
from WT animals (n = 11) before (solid line) and after (dashed line) non-sedative diazepam injections (0.75 mg/
kg). (B) Effect of diazepam on power of indicated EEG bands in WT animals. (C) Active wake power spectra 
from γ2* animals (n = 9) before and after non-sedative diazepam injections, inset percent difference of active 
wake power spectra from WT baseline, of WT after diazepam (black dashed line), γ2* baseline (red solid line), 
and γ2* after diazepam (red dashed line). (D) Effect of diazepam on EEG band power in γ2* animals. The result 
of a three-way ANOVA showed a significant interaction among frequency, genotype, and drug (F, (4, 90) = 5.25, 
P = 7e-4) and between drug and genotype (F(1,90) = 27.79, P = 9.2e-7). Comparisons in (B,D) show the results 
of false-discovery adjusted t tests as described in the Methods.
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